List of Tables
Table 1. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Competitive Situation by Manufacturers in 2023
Table 4. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Manufacturers (2019-2024)
Table 6. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market T Cell-specific Surface Glycoprotein CD28 Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of T Cell-specific Surface Glycoprotein CD28 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of T Cell-specific Surface Glycoprotein CD28 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global T Cell-specific Surface Glycoprotein CD28 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T Cell-specific Surface Glycoprotein CD28 Antibody as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2019-2024) & (K Units)
Table 18. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2019-2024)
Table 19. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2025-2030) & (K Units)
Table 20. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2025-2030)
Table 21. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2019-2024)
Table 23. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2025-2030)
Table 25. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2019-2024) & (K Units)
Table 27. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2025-2030) & (K Units)
Table 28. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2019-2024) & (K Units)
Table 32. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2025-2030) & (K Units)
Table 33. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2019-2024) & (K Units)
Table 42. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2025-2030) & (K Units)
Table 43. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Type (2019-2024)
Table 51. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Type (2025-2030)
Table 52. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Type (2019-2024)
Table 53. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Type (2025-2030)
Table 54. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Type (2019-2024)
Table 55. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Type (2025-2030)
Table 56. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Type (2019-2024)
Table 57. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Type (2025-2030)
Table 58. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2019-2024)
Table 59. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2025-2030)
Table 60. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Application (2019-2024)
Table 61. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units) by Application (2025-2030)
Table 62. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Application (2019-2024)
Table 63. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Application (2025-2030)
Table 64. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Application (2019-2024)
Table 65. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue (US$ Million) by Application (2025-2030)
Table 66. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Application (2019-2024)
Table 67. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Application (2025-2030)
Table 68. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2019-2024)
Table 69. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2025-2030)
Table 70. Sino Biological, Inc. Corporation Information
Table 71. Sino Biological, Inc. Description and Business Overview
Table 72. Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sino Biological, Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 74. Sino Biological, Inc. Recent Developments/Updates
Table 75. Abcam Corporation Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abcam T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 79. Abcam Recent Developments/Updates
Table 80. Thermo Fisher Corporation Information
Table 81. Thermo Fisher Description and Business Overview
Table 82. Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Thermo Fisher T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 84. Thermo Fisher Recent Developments/Updates
Table 85. Bio-Techne Corporation Information
Table 86. Bio-Techne Description and Business Overview
Table 87. Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bio-Techne T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 89. Bio-Techne Recent Developments/Updates
Table 90. BioLegend Corporation Information
Table 91. BioLegend Description and Business Overview
Table 92. BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioLegend T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 94. BioLegend Recent Developments/Updates
Table 95. LifeSpan BioSciences, Inc Corporation Information
Table 96. LifeSpan BioSciences, Inc Description and Business Overview
Table 97. LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. LifeSpan BioSciences, Inc T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 99. LifeSpan BioSciences, Inc Recent Developments/Updates
Table 100. Elabscience Biotechnology Inc. Corporation Information
Table 101. Elabscience Biotechnology Inc. Description and Business Overview
Table 102. Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Elabscience Biotechnology Inc. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 104. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 105. Boster Biological Technology Corporation Information
Table 106. Boster Biological Technology Description and Business Overview
Table 107. Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Boster Biological Technology T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 109. Boster Biological Technology Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Merck T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 114. Merck Recent Developments/Updates
Table 115. Wuhan Fine Biotech Co., Ltd. Corporation Information
Table 116. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
Table 117. Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Wuhan Fine Biotech Co., Ltd. T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 119. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
Table 120. ProSci Incorporated Corporation Information
Table 121. ProSci Incorporated Description and Business Overview
Table 122. ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. ProSci Incorporated T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 124. ProSci Incorporated Recent Developments/Updates
Table 125. Abbexa Corporation Information
Table 126. Abbexa Description and Business Overview
Table 127. Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Abbexa T Cell-specific Surface Glycoprotein CD28 Antibody Product
Table 129. Abbexa Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. T Cell-specific Surface Glycoprotein CD28 Antibody Distributors List
Table 133. T Cell-specific Surface Glycoprotein CD28 Antibody Customers List
Table 134. T Cell-specific Surface Glycoprotein CD28 Antibody Market Trends
Table 135. T Cell-specific Surface Glycoprotein CD28 Antibody Market Drivers
Table 136. T Cell-specific Surface Glycoprotein CD28 Antibody Market Challenges
Table 137. T Cell-specific Surface Glycoprotein CD28 Antibody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of T Cell-specific Surface Glycoprotein CD28 Antibody
Figure 2. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Type in 2023 & 2030
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Application in 2023 & 2030
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size (2019-2030) & (US$ Million)
Figure 16. Global T Cell-specific Surface Glycoprotein CD28 Antibody Sales (2019-2030) & (K Units)
Figure 17. Global T Cell-specific Surface Glycoprotein CD28 Antibody Average Price (US$/Unit) & (2019-2030)
Figure 18. T Cell-specific Surface Glycoprotein CD28 Antibody Report Years Considered
Figure 19. T Cell-specific Surface Glycoprotein CD28 Antibody Sales Share by Manufacturers in 2023
Figure 20. Global T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest T Cell-specific Surface Glycoprotein CD28 Antibody Players: Market Share by Revenue in 2023
Figure 22. T Cell-specific Surface Glycoprotein CD28 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global T Cell-specific Surface Glycoprotein CD28 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2019-2030)
Figure 25. North America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2019-2030)
Figure 26. United States T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2019-2030)
Figure 29. Europe T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2019-2030)
Figure 30. Germany T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Region (2019-2030)
Figure 37. China T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2019-2030)
Figure 45. Latin America T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2019-2030)
Figure 46. Mexico T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Market Share by Country (2019-2030)
Figure 51. Turkey T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE T Cell-specific Surface Glycoprotein CD28 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Type (2019-2030)
Figure 55. Global Revenue Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Type (2019-2030)
Figure 56. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Application (2019-2030)
Figure 58. Global Revenue Market Share of T Cell-specific Surface Glycoprotein CD28 Antibody by Application (2019-2030)
Figure 59. Global T Cell-specific Surface Glycoprotein CD28 Antibody Price (US$/Unit) by Application (2019-2030)
Figure 60. T Cell-specific Surface Glycoprotein CD28 Antibody Value Chain
Figure 61. T Cell-specific Surface Glycoprotein CD28 Antibody Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
